This site is intended for health professionals only

Published on 9 July 2007

Share this story:

AstraZeneca enters RNA interference field


AstraZeneca has signed a deal with the UK’s Silence Therapeutics that is worth up to

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine